Evidence map›Paper›PMID 35708238›Full record

ArticleStatistics in medicine2022

Regression modeling of restricted mean survival time for left-truncated right-censored data.

Rong Rong, Jing Ning, Hong Zhu

Abstract read
In one paragraph

Article in Statistics in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rong RongDepartment of Statistical Science, Southern Methodist University, Dallas, Texas, USA.
Jing NingDepartment of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0002-5289-331X
Hong ZhuDivision of BiostatisticsDepartment of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, USA.ORCID 0000-0001-8562-3351

Funding

UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
Comparative Effectiveness of Cancer Research: Use Data from Multiple SourcesR01CA193878 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI NING, JING · 2016 to 2019
$1.2M
NCI NIH HHS P30 CA142543NCI NIH HHS R01 CA193878NIH HHS 2P30CA142543NIH HHS R01CA193878
6 · The paper itself

Abstract

The restricted mean survival time (RMST) is a clinically meaningful summary measure in studies with survival outcomes. Statistical methods have been developed for regression analysis of RMST to investigate impacts of covariates on RMST, which is a useful alternative to the Cox regression analysis. However, existing methods for regression modeling of RMST are not applicable to left-truncated right-censored data that arise frequently in prevalent cohort studies, for which the sampling bias due to left truncation and informative censoring induced by the prevalent sampling scheme must be properly addressed. The pseudo-observation (PO) approach has been used in regression modeling of RMST for right-censored data and competing-risks data. For left-truncated right-censored data, we propose to directly model RMST as a function of baseline covariates based on POs under general censoring mechanisms. We adjust for the potential covariate-dependent censoring or dependent censoring by the inverse probability of censoring weighting method. We establish large sample properties of the proposed estimators and assess their finite sample performances by simulation studies under various scenarios. We apply the proposed methods to a prevalent cohort of women diagnosed with stage IV breast cancer identified from surveillance, epidemiology, and end results-medicare linked database.

Indexed as

MedicareAgedComputer SimulationFemaleHumansProbabilityRegression AnalysisSurvival AnalysisSurvival RateUnited Statesgeneral censoring mechanismsinverse probability of censoring weightingleft-truncated right-censored datapseudo-observationsrestricted mean survival time

Identifiers

PMID35708238
PMCPMC10014036

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.